Viridian Therapeutics
VRDN
VRDN
72 hedge funds and large institutions have $459M invested in Viridian Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% less capital invested
Capital invested by funds: $460M → $459M (-$1.24M)
10.87% less ownership
Funds ownership: 107.09% → 96.22% (-11%)
Holders
72
Holding in Top 10
8
Calls
$2M
Puts
–
Top Buyers
| 1 | +$12.9M | |
| 2 | +$9.49M | |
| 3 | +$5.58M | |
| 4 |
CC
Commodore Capital
New York
|
+$1.92M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.8M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$4.41M | |
| 3 | -$3.2M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$3.08M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$2.5M |